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ity, with signiﬁcant correlations between the ratings 12 and 15
months for all items except one. Cronbach’s alpha was found to
be 0.91. CONCLUSION: The Swedish translation of GIQLI has
a high validity and reliability for assessing gallstone-related
symptoms.
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OBJECTIVES: To describe the relationship between symptoms
of gastroesophageal reﬂux disease (GERD) and self-reported
concomitant diseases, health-related quality of life and work pro-
ductivity. METHODS: An exploratory database analysis was
performed on results from the 2004 National Health and Well-
ness Survey. US respondents with self-reported symptoms of
GERD (n = 10,028, mean age: 52 years, 58% female) were age-
and sex-matched to controls without GERD symptoms (n =
10,028). Information on health-related quality of life was
obtained using the Short-Form (SF)-8 questionnaire. Data on
health-related reduced productivity while at work or when per-
forming daily activities were obtained using the generic version
of the Work Productivity and Activity Impairment questionnaire.
Respondents with GERD were classiﬁed by self-reported
symptom severity (mild, moderate or severe) and frequency (low
or medium-to-high: symptoms on <2 days or ≥2 days per week,
respectively). RESULTS: Respondents with GERD had the fol-
lowing distribution with regard to symptom severity and fre-
quency: 52% had mild and low; 12% mild and medium-to-high;
10% moderate and low; 18% moderate and medium-to-high;
2% severe and low; 6% severe and medium-to-high. Compared
with controls, respondents with GERD symptoms had a larger
number of concomitant diseases (mean difference [MD]: 1.6),
lower SF-8 physical and mental health scores (MD: 4.1 and 3.1
units, respectively), more absence from work (MD: 0.9 hours per
week), and a higher percentage of health-related reduced pro-
ductivity while at work (MD: 7.5% units) and when performing
daily activities (MD: 12.1% units). The difference between the
control group and respondents with GERD increased with
increasing symptom severity and/or frequency for all variables.
CONCLUSION: Increasing severity and frequency of GERD
symptoms is associated with more concomitant diseases, lower
health-related quality of life, and reduced work productivity.
Further studies are needed to help identify patient populations
in which re-evaluating the management of GERD may be 
warranted.
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OBJECTIVES: To evaluate the impact of gastroesophageal reﬂux
disease (GERD) on health-related quality of life (HRQoL) of
affected individuals in Shanghai. METHODS: A representative
sample of 1200 adults was selected using a randomized cluster
sampling method. Subjects completed mainland Chinese versions
of the Reﬂux Disease Questionnaire (RDQ), GERD Impact Scale
(GIS), Quality of Life in Reﬂux and Dyspepsia questionnaire
(QOLRAD) and Short Form-36 (SF-36). A clinically meaningful
impairment of HRQoL was deﬁned as a statistically signiﬁcant
decrease of ≥ 0.5 points in a 7-point QOLRAD domain or ≥ 5
points in a 100-point SF-36 domain. RESULTS: 1034 subjects
completed the survey (response rate: 86.2%); 919 responses were
suitable for analysis (mean age: 46.7 years; 55.4% female). Sub-
jects with GERD (n = 57) had meaningfully impaired HRQoL
compared with subjects without GERD (n = 862) in terms 
of impaired vitality (mean QOLRAD scores: 6.34 vs 7.00),
food/drink problems (6.39 vs 7.00) and emotional distress (6.46
vs 7.00) (all ≤ 0.001), but not sleep disturbance (6.54 vs 7.00)
and impaired physical/social functioning (6.67 vs 7.00) (both P
≤ 0.001); and in the SF-36 dimensions of role-physical (mean SF-
36 scores: 71.9 vs 95.2), general health (49.2 vs 70.1), role-
emotional (76.6 vs 96.4), bodily pain (76.3 vs 95.8), vitality
(54.9 vs 72.9), mental health (71.9 vs 82.4) and physical func-
tion (81.4 vs 90.3) (all P < 0.001) but not social function (90.6
vs 94.5, P = 0.02). According to the GIS, the most common prob-
lems caused by GERD were interference with eating and drink-
ing (4.1% of the study population), sleep impairment (2.5%) and
reduced work productivity (2.5%). CONCLUSION: GERD has
a clinically meaningful impact on the HRQoL of affected indi-
viduals in the general population of Shanghai. Further research
is needed to assess how this effect responds to appropriate acid-
suppressive therapy.
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OBJECTIVES: To examine differences in length of stay and inpa-
tient mortality between hospitalizations for patients with sickle
cell disease (SCD) versus patients without SCD undergoing high-
volume surgical procedures. METHODS: We analyzed data
from the 2004 Nationwide Inpatient Sample (NIS) from the
Health care Cost and Utilization Project. Clinical Classiﬁcation
Software (CCS) codes were used to identify discharges for
patients who underwent one of six surgical procedures: (CCS 45)
percutaneous transluminal coronary angioplasty (PTCA), (CCS
80) appendectomy, (CCS 84) cholecystectomy, (CCS 124) hys-
terectomy, (CCS 152) arthroplastic knee surgery, and (CCS 153)
hip replacement. CCS code 61 was used to identify patients with
SCD. National estimates were computed using weights provided
in the NIS, and unadjusted comparisons of demographic and
outcome variables between SCD and non-SCD were performed
using chi-square and t-tests as appropriate. To adjust for corre-
lations within hospitals, generalized estimating equations were
used to compare length of stay (LOS) and inpatient mortality
controlling for age and comorbidities. RESULTS: SCD patients
undergoing all six surgical procedures were signiﬁcantly younger
than non-SCD patients. In unadjusted analyses, inpatient LOS
was longer in SCD vs. non-SCD patients (PTCA: 2.9 vs. 2.8 days;
appendectomy: 5.5 vs. 2.9; cholecystectomy: 6.3 vs. 4.7; hys-
terectomy: 3.4 vs. 2.7; knee arthroplasty: 5.4 vs. 3.9 and hip
